Blenamax is a medicine containing the active ingredient(s) bleomycin. On this page you will find out more about Blenamax, including side effects, age restrictions, food interactions and whether the medicine is subsidised by the government on the pharmaceutical benefits scheme (PBS)
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional. healthdirect medicines information is not intended for use in an emergency. If you are suffering an acute illness, overdose, or emergency condition, call triple zero (000) and ask for an ambulance.
Reasonable care has been taken to provide accurate information at the time of creation. This information is not intended to substitute medical advice, diagnosis or treatment and should not be exclusively relied on to manage or diagnose a medical condition. Please refer to our terms and conditions.
Active ingredient in this medicine: bleomycin
Information for medicine and pack size:
Blenamax 15 000 international units powder for injection, 10 vials
Consumer Medicine Information leaflet:
This leaflet may also be found inside the medicine package. It contains information on side effects, age restrictions and other useful data.
What this medicine is for
Bleomycin is used for palliative treatment and/or adjuvant treatment to surgery and/or radiation therapy in the management of the following neoplasms: The primary indication is the treatment of squamous cell carcinoma of the skin, head and neck and oesophagus. Tumour response has also been obtained in a number of patients with squamous cell carcinoma of the penis, larynx and uterine cervix. Squamous cell carcinoma of the bronchus has shown infrequent response. Bleomycin is also indicated in the treatment of choriocarcinoma and embryonal cell carcinoma of the testis. It has been used effectively in advanced Hodgkin's disease and in some cases of other lymphomas such as Non-Hodgkin's lymphoma and in mycosis fungoides. Bleomycin is bone-marrow sparing and may therefore be of use when other cytotoxic Agents are contraindicated. It should be noted that treatment of patients with bleomycin after radiation therapy is less successful than treatment prior to radiation therapy. Bleomycin is effective as a sclerosing agent for the treatment of malignant pleural effusion. It should be given as a single instillation only, as studies have not assessed the efficacy or safety of multiple intrapleural dosing.
Table of characteristics
|Visual appearance||Cake of white powder in a vial|
|Dosage Form||Injection, powder for|
|Route of administration||Intravenous|
1 vial: Prescription Only Medicine, or Prescription Animal Remedy
There is one type of pack available.
Pack type 1
|Storage temperature||Store at 2 to 8 degrees Celsius|
|Storage conditions||Protect from Light|
|Life time||3 Years|
We were unable to verify that this medicine is available on the PBS (Pharmaceutical Benefits Scheme). Please consult your pharmacist if you need further information
The PBS provides a list of government subsidised medicines available to be dispensed to patients. Further information can be found on the Pharmaceutical Benefits Scheme website.
Is this medication banned in sport?
Check if you can use your medicine whilst playing sport. Search the Australian Sports Anti-Doping Authority (ASADA) database that provides information about the prohibited status of specific medications and/or the active ingredient based on the current World Anti-Doping Agency (WADA) Prohibited List.
Found 2 results
Blenamax | myVMC
Blenamax is an antineoplastic antibiotic used to treat squamous cell carcinoma in combination with radiotherapy or surgery. It contains bleomycin sulfate.
Read more on myVMC – Virtual Medical Centre website
Blenamax Powder for injection - myDr.com.au
Blenamax Powder for injection - Consumer Medicines Information leaflets of prescription and over-the-counter medicines
Read more on myDr – Consumer Medicine Information website
Found 0 results